Basic Information
Affini-T Therapeutics is a biotechnology company developing T-cell therapies for cancer patients. Affini-T uses a proven platform to select high-affinity T-cell receptors targeting oncogenic mutations, paving the way for cutting-edge solid tumor therapies. Affini-T leverages gene editing and synthetic biology to engineer novel T-cell therapies aimed at eradicating tumors.